OXYGENTA PHARMACEUTICAL LIMITE Share Price

OXYGENTA PHARMACEUTICAL LIMITE Share Price

BSE: 524636
|
Pharmaceuticals
₹ 51.35
+₹3.10 (6.42%)
1D
Last updated 24 Jul, 2026, 15:29 IST

OXYGENTA PHARMACEUTICAL LIMITE Share Price Today

As of 25 Jul 2026, OXYGENTA PHARMACEUTICAL LIMITE share price is ₹51.35. The stock opened at ₹49.00, compared to its previous close of ₹48.25. During today's trading session, OXYGENTA PHARMACEUTICAL LIMITE share price moved in the range of ₹48.50 to ₹51.35, with an average price of ₹49.92 for the day. Looking at its last 52-week, the stock has touched a low of ₹43.00 and a high of ₹110.25.

₹48.50
6.42% up today
₹51.35
1D LOW
1D HIGH

OXYGENTA PHARMACEUTICAL LIMITE Returns Calculator

Circuit
L
H
₹40.73
₹61.09
52-week
L
H
₹43.00
₹110.25
Mkt Cap Cr
178.45
P/E
-10.16
P/B
0.00
ROE
41.16%
D/E
-2.57
ROCE
-26.02%
Div. Yield
0.00%
EPS(TTM)
-4.75
Turnover
3.36
EV/EBITDA
-19.22
Net Margin
0.00%
Op. Margin
0.00%
ROA
-14.69%
Quick Ratio
0.00
Curr. Ratio
0.99
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Oxygenta Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Oxygenta Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

OXYGENTA PHARMACEUTICAL LIMITE Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹109.30₹39.64₹30.99₹60.52
Other Income₹1.31₹0.04₹0.02₹0.00
Total Revenue₹110.61₹39.68₹31.01₹60.53
Total Expenses₹121.84₹53.59₹41.64₹61.57
Profit Before Tax-₹11.55-₹13.87-₹11.37-₹0.49
Tax-₹1.87-₹10.39₹0.20₹0.12
Profit After Tax-₹9.68-₹3.48-₹11.57-₹0.61
EPS - Basic-₹2.69-₹1.09-₹8.15-₹0.48
EPS - Diluted-₹2.69-₹1.04-₹8.15-₹0.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹11.55-₹13.87-₹11.37-₹0.49
Income before WC changes-₹9.07-₹9.56-₹7.84₹2.02
Change in Assets-₹7.63₹1.25-₹15.54₹5.75
Change in Liabilities₹19.46-₹4.73₹21.75-₹9.33
Change in WC₹11.83-₹3.49₹6.20-₹3.58
Cash flow from Operations₹2.60-₹13.05-₹1.63-₹1.68
Cash flow from Investing-₹11.25-₹4.09-₹9.64-₹4.94
Cash flow from Financing₹8.67₹17.13₹11.22₹6.33
Total Cash Flow₹0.02-₹0.01-₹0.05-₹0.29
Cash (Start of the year)₹0.10₹0.11₹0.16₹0.45
Cash (End of the year)₹0.12₹0.10₹0.11₹0.16

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹52.48₹39.09₹29.26₹21.61
Current Assets₹30.94₹24.11₹25.01₹9.56
Total Assets₹83.42₹63.19₹54.26₹31.18
Current Liabilities₹85.85₹33.70₹32.90₹8.07
Net Current Asset-₹54.90-₹9.59-₹7.89₹1.50
Non-Current Liabilities₹22.60₹49.62₹67.57₹57.74
Equity Capital-₹25.02-₹20.12-₹46.20-₹34.63
Total Equity & Liabilities₹83.42₹63.19₹54.26₹31.18
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
47.8
Neutral
ATR (14)
2.26
Neutral
STOCH(9,6)
25.05
Neutral
STOCH RSI (14)
46.18
Neutral
ADX(9)
26.29
Bearish
UO(9)
42.66
Neutral
ROC(12)
2.66
Bullish
WillR(14)
-62.44
Neutral
Period
Simple value
Exponential vaue
5D
48.91
48.86
10D
48.99
48.79
20D
48.51
48.76
50D
49.79
49.76
100D
51.14
51.47

About OXYGENTA PHARMACEUTICAL LIMITE

OXYGENTA PHARMACEUTICAL LIMITE Share Price
ISIN
INE102E01018
Sector Market Cap
₹ 178.45 Cr

Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State.

OXYGENTA PHARMACEUTICAL LIMITE Financial Highlights

  • Revenue: OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹113.27 crore in FY26 vs ₹110.61 crore in FY25. It showed an increase of 2.40% on a yearly basis.
  • Operating Profit: OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹22.18 crore in FY26 vs ₹14.35 crore in FY25. It showed a decrease of 54.56% on a year-on-year basis.
  • Net Profit: OXYGENTA PHARMACEUTICAL LIMITE reported a net loss of ₹17.57 crore in FY26 vs ₹10.30 crore in FY25. It showed a decrease of 70.58% on a yearly basis.

OXYGENTA PHARMACEUTICAL LIMITE Quarterly Result Highlights

  • OXYGENTA PHARMACEUTICAL LIMITE reported revenue of ₹49.78 crore in Mar 2026, compared with ₹33.93 crore in Dec 2025, representing an increase of 46.71% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported an operating loss of ₹1.28 crore in Mar 2026, compared with ₹6.33 crore in Dec 2025, representing an increase of 79.78% on a quarter-on-quarter (QoQ) basis.
  • OXYGENTA PHARMACEUTICAL LIMITE reported a loss of ₹1.70 crore in Mar 2026, compared with ₹4.84 crore in Dec 2025, reflecting an increase of 64.88% on a QoQ basis.
  • The earnings per share (EPS) of OXYGENTA PHARMACEUTICAL LIMITE stood at ₹2.69 during Mar 2026.
Know more
Promoters
56.54%
FII
0.00%
Other DII
0.00%
Retail and other
43.44%
Mutual funds
0.03%
Foreign institutions - FII
Compare against other stocks
OXYGENTA PHARMACEUTICAL LIMITE Share Price
OXYGENTA PHARMACEUTICAL LIMITE
Pharmaceuticals
Add Stock
Add Another

FAQs on OXYGENTA PHARMACEUTICAL LIMITE Share Price